SEC5 Antibody

What is SEC5/EXOC2 and why is it significant in cellular research?

SEC5/EXOC2 is a component of the octameric exocyst complex required for polarized secretion and membrane trafficking. The protein contains 924 amino acids with a calculated molecular weight of 104 kDa, though it is typically observed at 95-100 kDa in experimental conditions . SEC5 plays critical roles in the docking of exocytic vesicles with fusion sites on the plasma membrane and is widely expressed with highest levels in the brain and placenta .

The significance of SEC5 extends beyond exocytosis - research has demonstrated its unexpected presence on endocytic vesicles, particularly in association with clathrin-coated pits and vesicles, suggesting dual functions in both secretory and endocytic pathways . Quantitative analysis has shown that 59.5 ± 2.5% of all clathrin-coated pits and vesicles are labeled with anti-SEC5, with a 6.6-fold higher linear density of SEC5 labeling in coated pits and vesicles compared to other plasma membrane regions . Recent studies also suggest roles in trophoblast invasion during early pregnancy, indicating its importance in developmental processes .

What applications can SEC5 antibodies be used for in experimental research?

SEC5 antibodies can be utilized across multiple experimental applications with varying dilution requirements:

For optimal results, researchers should titrate the antibody in each testing system as the optimal concentration may be sample-dependent .

How can I validate the specificity of SEC5 antibodies in my experimental system?

Validating specificity requires multiple approaches. The gold standard involves using knockout or knockdown models as negative controls. Published research has validated SEC5 antibody specificity using hypomorphic alleles (e.g., Sec5E13) where the antibody recognition region is absent .

When using SEC5 antibodies, perform Western blotting to confirm the detection of a single band at the expected molecular weight (95-100 kDa). Cross-reactivity can be assessed by comparing wild-type and SEC5-deficient samples - genuine SEC5 bands should be absent in knockout/knockdown samples . For immunofluorescence validation, parallel staining of wild-type and SEC5-depleted cells provides visual confirmation of specificity, while co-localization with known SEC5 interacting partners can provide additional verification of target recognition .

What are the subcellular localization patterns of SEC5 and how do they vary between different cell types?

SEC5 exhibits complex and dynamic subcellular localization patterns that vary significantly between cell types and developmental stages. In Drosophila oocytes, SEC5 shows enrichment in the oocyte compared to nurse cells, with a shift from cytoplasmic to predominantly plasma membrane-associated distribution upon initiation of vitellogenesis at stage 8 .

Immunoelectron microscopy has revealed that a substantial proportion of SEC5 associates with clathrin-coated pits and vesicles beneath the plasma membrane. Quantitative analysis shows that approximately 41 ± 4% of total SEC5 labeling is found on these structures, while 30 ± 9% localizes to noncoated plasma membrane or endocytic structures and 29 ± 8% is found in the cytoplasm .

In human placental tissues, SEC5 expression shows developmental regulation, with high expression in cytotrophoblasts (CTBs) and extravillous trophoblasts (EVTs) during early pregnancy . This temporal and spatial regulation suggests context-specific functions for SEC5 beyond its canonical role in exocytosis.

How can SEC5 antibodies be optimized for challenging samples or low-abundance detection?

For challenging samples or detecting low-abundance SEC5, consider these methodological optimizations:

• Signal amplification systems: For Western blotting, use high-sensitivity ECL substrates or fluorescent secondary antibodies with digital imaging systems to enhance detection without increasing background.

• Sample enrichment strategies: For low-abundance samples, perform subcellular fractionation to enrich membrane-associated proteins before Western blotting or immunoprecipitation. This approach is particularly effective since SEC5 shows enrichment in specific membrane compartments .

• Antigen retrieval optimization: For IHC applications, SEC5 detection benefits from specific retrieval methods. Evidence suggests using TE buffer pH 9.0 for optimal results, though citrate buffer pH 6.0 may serve as an alternative .

• Extended antibody incubation: For detection in tissues with potentially low SEC5 expression, extend primary antibody incubation to overnight at 4°C using the higher end of the recommended concentration range (1:20-1:50 for IHC applications) .

• Tyramide signal amplification (TSA): For fluorescence applications with low signal, implement TSA systems that can increase sensitivity by 10-100 fold while maintaining signal specificity.

What are the key considerations when designing co-immunoprecipitation experiments with SEC5 antibodies?

Co-immunoprecipitation (Co-IP) with SEC5 antibodies requires careful experimental design:

What is the optimal Western blotting protocol for SEC5 antibody detection?

For optimal SEC5 detection by Western blotting:

• Sample preparation:

  • Extract proteins using RIPA buffer supplemented with protease inhibitors

  • Heat samples at 95°C for 5 minutes in Laemmli buffer with reducing agent

  • Load 20-50 μg of total protein per lane (brain or placental samples yield best results)

• Gel electrophoresis and transfer:

  • Use 8% SDS-PAGE gels to achieve good separation around the 95-100 kDa range

  • Transfer to PVDF membrane (preferred over nitrocellulose for SEC5) using wet transfer at 100V for 90 minutes with cooling

• Blocking and antibody incubation:

  • Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Incubate with primary SEC5 antibody (1:500-1:1000 dilution) overnight at 4°C

  • Wash 3 × 10 minutes with TBST

  • Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature

• Detection:

  • Expected band size: 95-100 kDa

  • Signal can be detected using standard ECL reagents

  • For quantitative analysis, consider fluorescent secondary antibodies and digital imaging

• Validation controls:

  • Use SEC5 knockdown/knockout samples as negative controls

  • Consider loading gradient to demonstrate antibody sensitivity and linearity

What immunohistochemistry protocol yields the best results for SEC5 detection in tissue sections?

For optimal IHC results with SEC5 antibodies:

• Tissue preparation:

  • Fix tissues in 10% neutral buffered formalin for 24-48 hours

  • Process and embed in paraffin following standard protocols

  • Cut sections at 4-5 μm thickness

• Deparaffinization and antigen retrieval:

  • Deparaffinize sections in xylene and rehydrate through graded alcohols

  • Critical step: For SEC5, use TE buffer pH 9.0 for antigen retrieval (heat-induced epitope retrieval at 95-98°C for 15-20 minutes)

  • Alternative: citrate buffer pH 6.0 if TE buffer yields high background

• Blocking and antibody incubation:

  • Block endogenous peroxidase with 3% H₂O₂ for 10 minutes

  • Block non-specific binding with 5% normal goat serum for 1 hour

  • Incubate with SEC5 antibody at 1:20-1:200 dilution (start with 1:50 for optimization)

  • Incubate overnight at 4°C in a humidified chamber

• Detection and visualization:

  • Use polymer-based detection systems for increased sensitivity

  • Develop with DAB and counterstain with hematoxylin

  • Mount with permanent mounting medium

• Controls and validation:

  • Include SEC5-high (brain, placenta) and SEC5-low tissues

  • SEC5 staining has been validated in human breast cancer tissue

  • Expect enrichment in trophoblasts in placental sections based on published findings

How can I optimize immunofluorescence protocols for detecting SEC5 in cultured cells?

For high-quality immunofluorescence detection of SEC5:

• Cell preparation:

  • Culture cells on glass coverslips or chamber slides

  • Fix with 4% paraformaldehyde for 15 minutes at room temperature

  • Permeabilize with 0.2% Triton X-100 in PBS for 10 minutes

• Blocking and antibody incubation:

  • Block with 5% normal serum (from secondary antibody host species) with 0.1% BSA in PBS for 1 hour

  • Incubate with SEC5 antibody at 1:50-1:500 dilution (begin with 1:100 for optimization)

  • Incubate overnight at 4°C in a humidified chamber

• Detection and imaging:

  • Use fluorophore-conjugated secondary antibodies (Alexa Fluor dyes recommended)

  • Include DAPI nuclear counterstain

  • For co-localization studies, combine with markers for:

    • Plasma membrane (e.g., Na⁺/K⁺ ATPase)

    • Clathrin-coated vesicles (e.g., clathrin heavy chain)

    • Other exocyst components

• Expected patterns:

  • Primarily membrane-associated staining with punctate distribution

  • Enrichment in membrane ruffles or cell-cell junctions

  • Partial co-localization with endocytic markers based on ultrastructural findings

• Advanced techniques:

  • For dynamic studies, consider live-cell imaging with GFP-tagged SEC5

  • Super-resolution microscopy (STED, STORM) can resolve SEC5 distribution in membrane microdomains

What are common issues when working with SEC5 antibodies and how can they be resolved?

Recommendation: For each new lot of SEC5 antibody, perform validation with positive controls (brain tissue extracts) and, when possible, negative controls (SEC5 knockdown samples) .

How can researchers compare different SEC5 antibody clones for specific applications?

When selecting between multiple SEC5 antibody options:

• Epitope considerations:

  • N-terminal vs. C-terminal targeting antibodies may yield different results based on protein interactions or cleavage events

  • The well-validated Proteintech SEC5 antibody (12751-1-AP) targets the full SEC5/EXOC2 fusion protein

• Cross-species reactivity assessment:

  • SEC5 antibodies show varied cross-reactivity profiles:

    • Some are specific to human, mouse, and rat samples

    • Others target SEC5 in model organisms like Drosophila or Saccharomyces

    • Select antibodies validated in your experimental species

• Application-specific validation:

  • For Western blotting: Compare signal-to-noise ratio and band specificity

  • For IHC/IF: Assess background levels and specificity of localization patterns

  • For IP applications: Compare pull-down efficiency by analyzing supernatant depletion

• Clone comparison strategy:

  • Run side-by-side tests using standardized protocols

  • Include positive controls (brain tissue) and, when possible, negative controls

  • Document and compare sensitivity, specificity, and reproducibility metrics

• Literature validation:

  • Review publication records for each antibody

  • The Proteintech SEC5 antibody has been cited in multiple publications for various applications including KD/KO validation (8 publications), WB (18 publications), IHC (1 publication), IF (7 publications), IP (1 publication), and CoIP (1 publication)

How are SEC5 antibodies being used to study membrane trafficking and secretion pathways?

SEC5 antibodies serve as valuable tools for investigating membrane trafficking mechanisms:

• Exocyst complex assembly studies:

  • SEC5 antibodies enable co-immunoprecipitation of other exocyst components to study complex formation and regulation

  • Immunofluorescence co-localization with other exocyst proteins (SEC3, SEC6, SEC8, etc.) reveals assembly dynamics

• Endocytic pathway investigations:

  • The unexpected finding of SEC5 on clathrin-coated pits and vesicles has opened new research directions

  • SEC5 antibodies allow tracking of these structures through immunoelectron microscopy and super-resolution imaging

• Developmental biology applications:

  • SEC5 expression in trophoblasts suggests roles in placental development

  • Antibodies enable tracking of SEC5 expression and localization changes during developmental processes

• Polarized secretion research:

  • In epithelial cells, SEC5 antibodies help map the distribution of exocyst components during establishment of cell polarity

  • This contributes to understanding directional membrane trafficking

• Pathological investigations:

  • SEC5 antibodies have been used to examine expression in pathological samples including breast cancer tissue

  • These studies may reveal connections between altered trafficking and disease states

What emerging techniques are enhancing SEC5 detection and functional analysis?

Emerging methodologies are expanding SEC5 research capabilities:

• Proximity labeling approaches:

  • BioID or APEX2 fusions with SEC5 enable identification of proximal proteins in living cells

  • These techniques complement traditional co-immunoprecipitation with SEC5 antibodies by revealing transient interactions

• Super-resolution microscopy:

  • STED, STORM, and PALM techniques overcome diffraction limits to resolve SEC5 distribution within membranous compartments

  • These approaches provide nanoscale visualization of SEC5 clustering and segregation

• Quantitative proteomics integration:

  • Combining SEC5 immunoprecipitation with mass spectrometry enables comprehensive interactome mapping

  • SILAC or TMT labeling allows comparative analysis across different cellular conditions

• Live-cell imaging advances:

  • Split fluorescent protein approaches allow visualization of SEC5 interactions in living cells

  • These techniques complement fixed-cell immunofluorescence with SEC5 antibodies

• CRISPR-based approaches:

  • Endogenous tagging of SEC5 with fluorescent proteins or epitope tags enables visualization of native protein

  • This approach reduces overexpression artifacts that might confound antibody-based detection

What considerations are important when using SEC5 antibodies in combination with antibody engineering techniques?

When incorporating SEC5 antibodies into advanced antibody engineering applications:

• Antibody fragmentation considerations:

  • F(ab) or F(ab')₂ fragments of SEC5 antibodies may provide advantages for immunofluorescence by reducing background

  • These fragments eliminate Fc-mediated binding that can cause non-specific signals

• Recombinant antibody production:

  • Converting SEC5 hybridoma-derived antibodies to recombinant formats increases reproducibility

  • This approach allows site-specific conjugation to fluorophores or enzymes at defined stoichiometry

• Bispecific antibody development:

  • Creating bispecific antibodies that recognize both SEC5 and interacting partners can enable visualization of complex formation

  • These tools are valuable for studying dynamic protein-protein interactions

• Antibody stability considerations:

  • For long-term storage and repeated use, antibody stability can be improved through rational sequence modification

  • Computational design strategies based on heuristic sequence analysis can systematically modify antibodies to improve stability and prevent precipitation in vitro

• Therapeutic antibody development insights:

  • Research on antibody optimization provides valuable lessons for improving research antibodies

  • Approaches that improve biophysical properties like thermal stability can enhance the performance of research-grade SEC5 antibodies